Fig. 40.8
Data from CHARM-Alternative.17 Candesartan reduced the combined edn-point of cardiovascular death or hospitalization for heart failure in patients unable to tolerate ACE inhibitor.

Data from CHARM-Alternative.17 Candesartan reduced the combined edn-point of cardiovascular death or hospitalization for heart failure in patients unable to tolerate ACE inhibitor.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close